Inhibition of angiotensin-converting enzyme by quercetin alters the vascular response to bradykinin and angiotensin I

Pharmacology

Volumn 65, Issue 4, 2002, Pages 182-186

  Hackl L P N ^a   Cuttle, G ^a   Sanches Dovichi, S ^a   Lima Landman, M T ^a   Nicolau, M ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Angiotensin I; Angiotensin converting enzyme inhibition; Blood pressure; Bradykinin; Quercetin

Indexed keywords

ANGIOTENSIN I; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; HEPARIN; HIPPURYLHISTIDYLLEUCINE; ICATIBANT; QUERCETIN; BRADYKININ RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASSOCIATION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG ANTAGONISM; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, ORAL; ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BRADYKININ; CAPTOPRIL; INJECTIONS, INTRAVENOUS; MALE; QUERCETIN; RATS; RATS, WISTAR; RECEPTORS, BRADYKININ;

EID: 0035996227     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064341     Document Type: Article

References (25)

1. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors
2. Bioregulation of kinins: Kallikreins, kininogens and kininases
3. Angiotensin receptors and their therapeutic implications
4. Angiotensin II receptors and angiotensin II receptor antagonists
5. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P
6. The angiotensin converting enzyme
7. Neutral endopeptidase 24.11: Structure, inhibition and experimental and clinical pharmacology
8. In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors
9. The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer
10. Antioxidant properties of phenolic compounds
11. Inhibition of metallopeptidases by flavonoids and related compounds
12. Potentiation by aminopeptidase P of blood pressure response to bradykinin
13. Hoe 140 a new potent and long acting bradykinin-antagonist: In vitro studies
14. An improved fluorimetric assay of rat serum and plasma converting enzyme
15. Hypotensive effect of captopril: Role of bradykinin and prostaglandin-like substances
16. Hoe 140, a potent and long acting bradykinin-antagonist: In vivo studies
17. Radical scavenging by flavonoid antioxidants
18. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte culture
19. Biological activity and future directions for flavonoids
20. Flavonoids as antioxidants
21. Antioxidant and chelating properties of flavonoids
22. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: Free radical scavenging versus iron chelating mechanism
23. In vitro screening of traditional medicines for anti-hypertensive effect based on inhibition of the angiotensin converting enzyme (ACE)
24. Inhibitory effects of various flavonoids isolated from leaves of persimmon on angiotensin-converting enzyme activity
25. Effect of quercetin on tachykinin-induced plasma extravasation in rat urinary bladder